Showing results (241-250 of 412) with videos related to
Sort By:
Pageof 42
Leukemia Research|April 6, 2010
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemiaJean-Marie Bruey, Hagop Kantarjian, Wanlong Ma, et al.Cancer|October 10, 2003
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndromeBarry D Hock, Judith L McKenzie, William Nigel Patton, et al.British Journal of Haematology|July 9, 2002
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndromeSrdan Verstovsek, Elihu Estey, Taghi Manshouri, et al.British Journal of Haematology|July 13, 2010
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation studyPaul G Richardson, Asher A Chanan-Khan, Melissa Alsina, et al.Cancer|January 30, 2002
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndromeRaymond Lai, Elihu Estey, Yu Shen, et al.Breast Cancer Research and Treatment|January 1, 1996
Abnormal expression of MDM-2 in breast carcinomasC E Bueso-Ramos, T Manshouri, M A Haidar, et al.Leukemia|September 26, 1997
Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemiaA W Bseiso, H M Kantarjian, J Q Guo, et al.Blood|January 5, 2017
Clonal evolution leading to ibrutinib resistance in chronic lymphocytic leukemiaInhye E Ahn, Chingiz Underbayev, Adam Albitar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Significance of FHIT expression in chronic myelogenous leukemiaH M Kantarjian, M Talpaz, S O'Brien, et al.Leukemia Research|April 27, 2000
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemiaF Ravandi-Kashani, S O'Brien, T Manshouri, et al.Pageof 42